Insider Selling: Phreesia (NYSE:PHR) Insider Sells $12,314.56 in Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,327 shares of the firm’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $9.28, for a total transaction of $12,314.56. Following the completion of the transaction, the insider owned 24,664 shares of the company’s stock, valued at approximately $228,881.92. The trade was a 5.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yvonne Hui also recently made the following trade(s):

• On Thursday, April 16th, Yvonne Hui sold 10,063 shares of Phreesia stock. The stock was sold at an average price of $9.08, for a total transaction of $91,372.04.

Phreesia Stock Performance

Shares of PHR opened at $8.83 on Friday. Phreesia, Inc. has a one year low of $7.77 and a one year high of $32.76. The company has a 50-day moving average of $10.70 and a two-hundred day moving average of $15.91. The stock has a market cap of $536.21 million, a price-to-earnings ratio of 294.17 and a beta of 0.86. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.53.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). The firm had revenue of $127.07 million during the quarter, compared to analyst estimates of $126.75 million. Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The business’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.11) earnings per share. On average, equities research analysts expect that Phreesia, Inc. will post 0.28 earnings per share for the current year.

Analysts Set New Price Targets

PHR has been the subject of several research reports. Needham & Company LLC decreased their price target on shares of Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, March 31st. Canaccord Genuity Group decreased their price target on shares of Phreesia from $33.00 to $22.00 and set a “buy” rating for the company in a report on Tuesday, March 31st. Zacks Research cut shares of Phreesia from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 6th. DA Davidson decreased their price target on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a report on Friday, January 23rd. Finally, Wall Street Zen cut shares of Phreesia from a “buy” rating to a “hold” rating in a report on Saturday, April 4th. Twelve investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Phreesia has a consensus rating of “Moderate Buy” and a consensus target price of $20.82.

Hedge Funds Weigh In On Phreesia

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Federated Hermes Inc. bought a new position in Phreesia during the third quarter valued at approximately $32,000. Van ECK Associates Corp raised its position in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after acquiring an additional 1,102 shares in the last quarter. Asset Management One Co. Ltd. bought a new position in Phreesia during the third quarter valued at approximately $45,000. Rockefeller Capital Management L.P. raised its position in Phreesia by 354.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock valued at $47,000 after acquiring an additional 2,149 shares in the last quarter. Finally, KBC Group NV raised its position in Phreesia by 83.4% during the fourth quarter. KBC Group NV now owns 3,449 shares of the company’s stock valued at $58,000 after acquiring an additional 1,568 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.